MSI-H/MMRd and MSS/ pMMR

Who we are

  • April 5, 2022
    A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
  • April 5, 2022
    Assessing the Immunogenicity of pING-hHER3FL
  • April 5, 2022
    Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
  • April 5, 2022
    Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors
  • April 5, 2022
    A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
  • April 5, 2022
    A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation
  • April 5, 2022
    PIPAC for the Treatment of Colorectal Peritoneal Metastases
  • April 5, 2022
    A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
  • April 5, 2022
    The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer
  • April 5, 2022
    Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer